The 16th Annual Meeting of ISMPP, April 20-22, 2020, in Washington, DC cancelled but will move to virtual format.
Share your expertise with the medical publishing community! The Publication Plan is now welcoming guest articles.
The latest State of Open Data survey results show changing trends in researchers’ attitudes towards the use of open data.
Scientific publishing is adapting to make research on COVID-19 and coronaviruses freely and rapidly available to all. But does the crisis highlight an opportunity for more fundamental reform?
Find out more about the TOP Factor, an alternative metric to the impact factor, evaluating academic journals based on open science policies.
Find out more about ISMPP’s guidance for navigating author non-responsiveness in the wake of the coronavirus pandemic.
Find out why guidance is needed and what’s covered in the new Synthesis Without Meta-analysis (SWiM) guidelines.
PLOS ONE now offers Registered Reports, shifting peer review focus from results to the quality of study design. Is this part of the future of open science?
Listen to patient partnership specialist Lauri Arnstein’s perspectives on the role of patients in medical publishing.
Find out more about why #EachforEqual is needed in scientific publishing and what you can do to support it.
In a recent article in Knowable magazine, Betsy Mason describes the benefits and pitfalls of different graphics and the need for better training in data visualisation.
Find out about the events and activities that took place for this year’s Rare Disease Day.
Jackie Marchington gives her perspective on the Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations.
Find out more about the impact the new ICMJE disclosure form will have on authors publishing in medical journals.
Find out more about the requirements cOAlition S plans to set for ‘transformative journals’.
With widespread and growing support for increased data sharing, what can we learn from the Yale Open Data Access (YODA) Project and its collaboration with Johnson & Johnson?
The reproducibility crisis is linked to publication bias and a paucity of negative data. Find out how and why to get such data published.